top of page
Browse by category
Search


First-in-human study of once-daily SYNT-101 oral treatment for obesity that mimics metabolic effects of gastric bypass without surgery
A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrated positive preliminary data for...


SYNT-101 once-daily oral treatment for obesity mimics RYGB
Syntis Bio has announced positive preclinical and first-in-human data for its lead candidate, SYNT-101, an investigational once-daily...
Browse by tag






bottom of page